Invention Grant
US08211923B2 Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
有权
取代的芳基磺酰氨基甲基膦酸衍生物，其制备及其在治疗I型和II型糖尿病中的应用
- Patent Title: Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
- Patent Title (中): 取代的芳基磺酰氨基甲基膦酸衍生物，其制备及其在治疗I型和II型糖尿病中的应用
-
Application No.: US12669979Application Date: 2008-07-25
-
Publication No.: US08211923B2Publication Date: 2012-07-03
- Inventor: Holger Wagner , Elke Langkopf , Matthias Eckhardt , Ruediger Streicher , Corinna Schoelch , Annette Schuler-Metz , Alexander Pautsch
- Applicant: Holger Wagner , Elke Langkopf , Matthias Eckhardt , Ruediger Streicher , Corinna Schoelch , Annette Schuler-Metz , Alexander Pautsch
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; David L. Kershner; Usha R. Patel
- Priority: DE102007035334 20070727
- International Application: PCT/EP2008/059807 WO 20080725
- International Announcement: WO2009/016119 WO 20090205
- Main IPC: A61K31/404
- IPC: A61K31/404 ; A61K31/416 ; A61K31/4184 ; A61K31/423 ; A61K31/428 ; C07D277/62 ; C07D263/54 ; C07D235/04 ; C07D231/56 ; C07D209/04
Abstract:
The present invention relates to substituted arylsulphonylaminomethyl-phosphonic acid derivatives of general formula wherein R, X, Y and Z are defined as in claim 1, the tautomers, enantiomers, diastereomers, mixtures thereof and salts thereof which have valuable pharmacological properties, particularly the suppression of the interaction of glycogen phosphorylase a with the GL subunit of glycogen-associated protein phosphatase 1 (PP1), and their use as pharmaceutical compositions.
Public/Granted literature
Information query
IPC分类:
